Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Naoya Odani"'
Autor:
Yasuko Mera, Takashi Kawai, Naoto Ogawa, Naoya Odani, Tomohiko Sasase, Katsuhiro Miyajima, Takeshi Ohta, Makoto Kakutani
Publikováno v:
Journal of Pharmacological Sciences, Vol 129, Iss 3, Pp 169-176 (2015)
JTT-130 was developed as an intestine-specific MTP inhibitor designed to rapidly catabolize after absorption to avoid causing hepatotoxicity due to hepatic MTP inhibition. In previous reports, we have demonstrated that JTT-130 suppresses dietary lipi
Externí odkaz:
https://doaj.org/article/6df01a5e373a4bec90a5262d41be7782
Autor:
Takahiro Hata, Naoya Odani, Masahiro Suzuki, Makoto Kakutani, Atsushi Hagiwara, Takashi Kawai, Takeo Katsushima, Yasuko Mera
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 336(2)
Inhibitors of microsomal triglyceride transfer protein (MTP) expressed in the liver and small intestine are potential candidates for lipid-lowering agents. However, inhibition of hepatic MTP could lead to significant safety issues such as fatty liver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60e827ffe69a3363eba09f023581fb37
https://pubmed.ncbi.nlm.nih.gov/20974698
https://pubmed.ncbi.nlm.nih.gov/20974698
Publikováno v:
Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 101(1)
We developed an automatic analyzing system using a personal computer to evaluate gastric motility objectively. Gastric motility was divided into three elements: motility index, amplitude and frequency. These elements analyzed with both computer and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b67b66beb052f857101bdc7d30819dcb
https://pubmed.ncbi.nlm.nih.gov/8444378
https://pubmed.ncbi.nlm.nih.gov/8444378
Autor:
Hiroshi Shibata, Naoya Odani
Publikováno v:
The Journal of toxicological sciences. 16(4)
The comparative study of the blood clearances of 99mTc-phytate (99mTc-P) and indocyanine green (ICG) was carried out in dogs with hepatic injury induced by carbon tetrachloride (CCl4), and the blood clearance of 99mTc-P or ICG was compared with the l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c6eaaf15ee191f08f0a76103e8aabf1
https://pubmed.ncbi.nlm.nih.gov/1798061
https://pubmed.ncbi.nlm.nih.gov/1798061
Publikováno v:
Japanese Journal of Pharmacology. 61:195
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd8c693f7f5084a6bcbb1d7472ecf256
https://doi.org/10.1016/s0021-5198(19)51657-2
https://doi.org/10.1016/s0021-5198(19)51657-2
Publikováno v:
Japanese Journal of Pharmacology. 55:126
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::357ee3c0ddde21a08916c091ac676d6c
https://doi.org/10.1016/s0021-5198(19)38389-1
https://doi.org/10.1016/s0021-5198(19)38389-1
Autor:
Yasuko Mera, Naoto Ogawa, Takashi Kawai, Makoto Kakutani, Naoya Odani, Takeshi Ohta, Katsuhiro Miyajima, Tomohiko Sasase
Publikováno v:
Journal of Pharmacological Sciences, Vol 129, Iss 3, Pp 169-176 (2015)
JTT-130 was developed as an intestine-specific MTP inhibitor designed to rapidly catabolize after absorption to avoid causing hepatotoxicity due to hepatic MTP inhibition. In previous reports, we have demonstrated that JTT-130 suppresses dietary lipi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51504b0e617526f782c6cbb3045adda7